Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-001485
Filing Date
2023-01-17
Accepted
2023-01-17 17:59:57
Documents
1
Period of Report
2023-01-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3477
  Complete submission text file 0001127602-23-001485.txt   5095
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
Business Address
Kelly Jason R (Reporting) CIK: 0001845677 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 23532433